Case Study

Thought Leaders Describe their Best Practices

One Project Team’s Evolution from Excel Spreadsheets to CDD Vault

Dale Cameron, Ph.D., Associate Director of Medicinal Chemistry, viDA Therapeutics

Design and development of new drugs is a difficult endeavor. Small companies can spend a large amount of time just managing data and communicating results, let alone on scientific innovation and finding new candidates for development. viDA Therapeutics was one such company, and their use of Excel files to track their important chemistry and biology data lacked transparency, control and efficiency. By implementing CDD Vault, they achieved better control of data, vastly improved collaboration, and the ability to track…
Download the full article here


Informatics Infrastructure for Public-Private Collaborations in Neglected Disease Research

Julio Martin, Ph.D. Head of Kinetoplastic Biology, GSK – Tres Cantos Open Lab
Published in Drug Target Review, Winter 2017, Issue 4

Efforts to develop new medicines for diseases of the developing world (DDW) have been somewhat fragmented in the past and progress has been limited, despite considerable investment. Public-private partnership (PPP) is becoming an essential model for research in neglected disease areas. However, collaboration on this scale presents unique challenges…
Download the full article here


Learn more about CDD Vault’s chemical registration, structure-activity relationship and collaborative data management capabilities. If you’re interested in learning about how it can help you in your research needs, write to us at info@collaborativedrug.com






Start your free trial




Translated with Google Translate